Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma
Sign Up to like & getrecommendations! Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14974
Abstract: Multiple myeloma (MM), a B cell malignancy characterized by clonal proliferation of plasma cells in the bone marrow, remains incurable despite the use of novel and conventional therapies. In this study, we demonstrated MM cell… read more here.
Keywords: nrea ato; anti activity; multiple myeloma; cell ... See more keywords